A Clinical Trial Hot Spot: Australia’s Attractions For Korean Firms

Citeline Podcasts

English - May 19, 2022 01:00 - 17 minutes - 40 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Cybin CEO: Big Pharma Can No Longer Sit On The Sidelines In Psychedelics

Next Episode: EU MedTech Forum 2022: Regulatory Predictability Impacts Renewed Calls For Devices Agency

Ausbiotech’s CEO and the Senior Trade and Investment Commissioner at the Australian Embassy in South Korea talk to Scrip’s Jung Won Shin on the sidelines of Bio Korea 2022 about what makes Australia an attractive clinical trial destination for Korean and other foreign firms, as well as collaborations and other opportunities between the two countries.